Copy of Corporate Information
Company Background & Operating History
Founded in 2011, MD Therapeutics has over a decade of experience in the development, manufacturing oversight, and international distribution of nutraceutical products. Since inception, the company has focused on building a sustainable, compliance-driven business supported by long-term partnerships with manufacturers, distributors, healthcare professionals, and retail channels.
This operating history reflects MD Therapeutics’ commitment to responsible growth, product integrity, and consistent quality standards across markets.
Distribution Model
MD Therapeutics operates a diversified, scalable distribution model designed to ensure product integrity while supporting international expansion. Our products are distributed through:
-
Appointed national and regional distribution partners
-
A dedicated local sales team working with licensed physicians and independent retail pharmacies
-
Direct-to-consumer e-commerce channels in markets where local representation has not yet been established
This multi-channel structure allows MD Therapeutics to maintain close oversight of product handling, regulatory alignment, and brand representation across different markets.
Quality & Manufacturing Standards
Quality assurance has been a core operating principle at MD Therapeutics since 2011.
Our nutraceutical products are developed and manufactured in accordance with internationally recognised standards, with stringent controls applied at every stage of the supply chain — from ingredient sourcing to final product release.
Key quality measures include:
-
Ingredient sourcing: Carefully selected, premium-grade botanical and nutritional ingredients
-
Purification & safety controls: Raw materials are purified and assessed to meet applicable safety and consumption standards
-
GMP-compliant manufacturing: Production is carried out in facilities located in the United States and Australia, operating under Good Manufacturing Practice (GMP) guidelines
-
Controlled logistics: Finished products are shipped to our Singapore logistics hub, where additional quality checks are performed prior to release to international distribution partners
This end-to-end process ensures consistency, safety, and regulatory readiness for global distribution.
Scientific & Clinical Responsibility
MD Therapeutics is committed to responsible product development guided by scientific evidence and clinical understanding. Where appropriate, formulations are developed with reference to established research on ingredient safety and functional support, in alignment with regulatory requirements for nutraceutical products.
Our long-standing objective is to deliver products that healthcare professionals, distributors, and consumers can rely on — built on more than a decade of operational experience, quality discipline, and regulatory awareness.
